Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Chemokine receptor modulators from Merck & Co. described in recent patent literature

March 8, 1999

Novel therapy for HIV/AIDS to enter clinical trials in the U.S.

March 2, 1999

Reticulose inhibits CCR5 receptor

March 2, 1999

Small pilot study demonstrates efficacy and safety of IL-2 with concomitant antiretroviral therapy

March 1, 1999

Nevirapine-containing triple combination therapy effective in advanced HIV disease or AIDS

Feb. 26, 1999

Strategic review of Novopharm Biotech's R&D program leads to discontinuation of GPI-2A

Feb. 25, 1999

NNRTIs from Boehringer Ingelheim effective against mutant viruses

Feb. 25, 1999

AZT-cyclam/bicyclam prodrug conjugates designed at INSERM

Feb. 18, 1999

Preventive AIDS vaccine trial to begin in Thailand

Feb. 18, 1999

Ligand introduces second new product this month

Feb. 17, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...